Rein Therapeutics Inc.
RNTX
$1.36
-$0.12-8.11%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.58M | -6.82M | -5.50M | -40.98M | -5.85M |
| Total Depreciation and Amortization | 0.00 | 1.00K | -- | 0.00 | 0.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.85M | 256.00K | 264.00K | 37.13M | 508.00K |
| Change in Net Operating Assets | 186.00K | 147.00K | -938.00K | -964.00K | 1.52M |
| Cash from Operations | -3.55M | -6.42M | -6.18M | -4.81M | -3.82M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 1.90M | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 1.25M | 738.00K | 1.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -251.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 3.47M | -- | 0.00 | -195.00K |
| Cash from Financing | 1.90M | 4.71M | 738.00K | 1.00K | -446.00K |
| Foreign Exchange rate Adjustments | -26.00K | -- | -- | -1.00K | 0.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.67M | -1.71M | -5.44M | -4.81M | -4.27M |